A Prospective, Randomized, Double-Blind Multicenter Trial of a Single Bolus Injection of the Novel Modified t-PA E6010 in the Treatment of Acute Myocardial Infarction: Comparison With Native t-PA

This publication has 14 references indexed in Scilit:

• Phase I Study of the Modified Tissue Plasminogen Activator E6010.
  Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics, 1994
• Intracoronary Infusion of E6010 Has More Potent Thrombolytic Activity Than Tissue Plasminogen Activator (t-PA) in Dogs: A Higher Plasma Level of E6010 Than t-PA Causes Potent Thrombolytic Activity
  Journal of Cardiovascular Pharmacology, 1993
• The Effects of Tissue Plasminogen Activator, Streptokinase, or Both on Coronary-Artery Patency, Ventricular Function, and Survival after Acute Myocardial Infarction
  New England Journal of Medicine, 1993
• An International Randomized Trial Comparing Four Thrombolytic Strategies for Acute Myocardial Infarction
  New England Journal of Medicine, 1993
• Randomized angiographic trial of recombinant tissue-type plasminogen activator (alteplase) in myocardial infarction
  Journal of the American College of Cardiology, 1992
• Thrombolytic Properties of a Novel Modified Human Tissue-Type Plasminogen Activator (E6010)
  Journal of Cardiovascular Pharmacology, 1991
• Intravenous recombinant tissue-type plasminogen activator in patients with acute myocardial infarction. A report from the multicenter thrombolysis trial.
  Japanese Circulation Journal, 1990
• Intravenous tissue plasminogen activator and size of infarct, left ventricular function, and survival in acute myocardial infarction.
  BMJ, 1988
• Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge.
  Circulation, 1987
• Early thrombolysis in acute myocardial infarction: Limitation of infarct size and improved survival
  Journal of the American College of Cardiology, 1986